戻る Agenda
Session 1: Advancing Health Equity for Diverse Populations
Session Chair(s)
Richardae Araojo, PharmD, MS
Associate Commissioner for Minority Health, Director, Office of Minority Health
FDA, United States
Christine Lee, PharmD, PhD
Deputy Director, Office of Minority Health and Health Equity (OMHHE), OC
FDA, United States
This session will highlight the FDA’s efforts to advance diversity and equity for racial and ethnic minorities, women, and rare diseases.
Learning Objective :
- Describe FDA efforts that advance clinical trial diversity for racial and ethnic minorities, women, and rare diseases
- Identify FDA efforts that support outreach and communication with racial and ethnic minority, women, and rare disease populations
- Discuss FDA’s collaborative research activities that support and advance health equity for racial and ethnic minorities, women, and rare diseases
Speaker(s)
FDA Office of Minority Health and Health Equity Efforts to Advance the Health of Racial and Ethnic Minorities
Richardae Araojo, PharmD, MS
FDA, United States
Associate Commissioner for Minority Health, Director, Office of Minority Health
FDA Office of Women’s Health Efforts to Advance the Health of Women
Kaveeta Vasisht, DrMed, MD, PharmD
FDA, United States
Associate Commissioner for Women's Health, Director of the Office of Women’s Hea
Rare Diseases—An Underserved Population
Sandra Retzky, DO, JD, MPH
U.S. Food and Drug Administration(FDA) , United States
Director, Office of Orphan Product Development, Office of the Commissioner